PRKAA2 and obesity disorder: TP63 knockout mice showed insulin resistance, obesity, and glucose intolerance; TP63 prevented these symptoms by increasing fatty acid synthesis and reducing fatty acid oxidation through the SIRT1/AMPKα2/LKB1 pathway [13].